Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Vascular Temporary Occlusion Equipment Supplied In Europe
5 equipment items found
Manufactured by:ISO Med based inChambly, FRANCE
ISOMed Occlusion Catheters - single lumen are made with X.R.O. polyurethane. They are colour coded for easy identification. The latex balloon, fixed with two sutures, is perfectly symmetrical. Occlusion catheters are gradated every 10 cm from the distal end, and are red-inforced with a removable steel wire. Double packaged - Sterile (ethylene ...
Manufactured by:Raumedic AG based inDietzenbach, GERMANY
Safety and flexibility in angiography thanks to high-pressure tubing. In angiography, blood vessels are made visible by means of X-rays (CT) or magnetic resonance (MRI). To identify even the smallest ramifications of the blood vessels, a contrast agent is required which is injected into the body with high pressure via the tubes. During the application, the high-pressure tubing must withstand the ...
Manufactured by:endox Feinwerktechnik GmbH based inDettingen/Erms, GERMANY
The „Flat Adenoma Resection Instrument (FARIn)“ was developed to treat especially large polyp-like and flat lesions > 2 cm bis ca. 4 cm en bloc near the muscularis propria and with low mechanical and thermal artifacts in a short time (pure resection time without marking, re-injection and cutting, < 1 min.) to be able to ...
Manufactured by:advanceCOR GmbH based inPlanegg, GERMANY
This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. Revacept is designed to protect the vessel walls so that vascular occlusion does not occur. Revacept has been shown to be well tolerated and effective ...
by:tiakis BIOTECH AG based inKiel, GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...